Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia
Corona Virus Disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a global pandemic. Currently there is no effective treatment for this disease, vaccination is one way to deal with this disease. Antibodies that are formed after vaccination are expe...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | Indonesian |
Published: |
Poltekkes Kemenkes Yogyakarta
2024-07-01
|
Series: | Jurnal Teknologi Laboratorium |
Subjects: | |
Online Access: | https://teknolabjournal.com/index.php/Jtl/article/view/447 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841560823567220736 |
---|---|
author | Heri Setiyo Bekti I Gusti Agung Ayu Dharmawati Nur Habibah Fusvita Merdekawati Ganjar Noviar I Putu Suiraoka Luh Putu Rinawati Rike Syahniar M. Ibraar Ayatullah |
author_facet | Heri Setiyo Bekti I Gusti Agung Ayu Dharmawati Nur Habibah Fusvita Merdekawati Ganjar Noviar I Putu Suiraoka Luh Putu Rinawati Rike Syahniar M. Ibraar Ayatullah |
author_sort | Heri Setiyo Bekti |
collection | DOAJ |
description | Corona Virus Disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a global pandemic. Currently there is no effective treatment for this disease, vaccination is one way to deal with this disease. Antibodies that are formed after vaccination are expected to provide protection for everyone. This study was to determine the levels of IgG antibodies formed after SARS-CoV-2 vaccination. 87 respondents were examined in this study using blood samples. Measurement of antibody levels using the CLIA method. The results obtained show that the average level of antibodies formed is 193.355 BAU/ml. 65 respondents who received 3 doses of vaccine (199.652 BAU/ml) had higher antibody levels than respondents who received two doses of vaccine (175.531 BAU/ml) and 1 dose of vaccine (158.365 BAU/ml). Antibody levels in respondents who were examined between 0-6 months after vaccination (202.827 BAU/ml) had higher levels than respondents with a period of more than six months (186.010 BAU/ml). From the study results, data was obtained that the antibody levels in recipients of three vaccine doses were higher so that they could provide sustainable protection against COVID-19. Therefore, the COVID-19 vaccine booster should give to all people to provide protection against COVID-19. |
format | Article |
id | doaj-art-fb63bc3cbc5a4b558279acd9539827ae |
institution | Kabale University |
issn | 2338-5634 2580-0191 |
language | Indonesian |
publishDate | 2024-07-01 |
publisher | Poltekkes Kemenkes Yogyakarta |
record_format | Article |
series | Jurnal Teknologi Laboratorium |
spelling | doaj-art-fb63bc3cbc5a4b558279acd9539827ae2025-01-03T15:40:12ZindPoltekkes Kemenkes YogyakartaJurnal Teknologi Laboratorium2338-56342580-01912024-07-01131253210.29238/teknolabjournal.v13i1.447399Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In IndonesiaHeri Setiyo Bekti0https://orcid.org/0000-0002-0780-5093I Gusti Agung Ayu Dharmawati1Nur Habibah2Fusvita Merdekawati3Ganjar NoviarI Putu Suiraoka4Luh Putu Rinawati5Rike Syahniar6M. Ibraar Ayatullah7Poltekkes Kemenkes DenpasarMedical Laboratory Technologist, Poltekkes Kemenkes Denpasar, Bali-Indonesia. Medical Laboratory Technologist, Poltekkes Kemenkes Denpasar, Bali-Indonesia. Medical Laboratory Technologist, Poltekkes Kemenkes Bandung, West Java-Indonesia. Medical Laboratory Technologist, Poltekkes Kemenkes Denpasar, Bali-Indonesia. Medical Laboratory Technologist, Poltekkes Kemenkes Denpasar, Bali-Indonesia. 4Department Microbiology and Parasitology, Faculty of Medicine and Health, Universitas Muhammadiyah Jakarta-IndonesiaDental Health, Poltekkes Kemenkes Kupang, Kupang-IndonesiaCorona Virus Disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become a global pandemic. Currently there is no effective treatment for this disease, vaccination is one way to deal with this disease. Antibodies that are formed after vaccination are expected to provide protection for everyone. This study was to determine the levels of IgG antibodies formed after SARS-CoV-2 vaccination. 87 respondents were examined in this study using blood samples. Measurement of antibody levels using the CLIA method. The results obtained show that the average level of antibodies formed is 193.355 BAU/ml. 65 respondents who received 3 doses of vaccine (199.652 BAU/ml) had higher antibody levels than respondents who received two doses of vaccine (175.531 BAU/ml) and 1 dose of vaccine (158.365 BAU/ml). Antibody levels in respondents who were examined between 0-6 months after vaccination (202.827 BAU/ml) had higher levels than respondents with a period of more than six months (186.010 BAU/ml). From the study results, data was obtained that the antibody levels in recipients of three vaccine doses were higher so that they could provide sustainable protection against COVID-19. Therefore, the COVID-19 vaccine booster should give to all people to provide protection against COVID-19.https://teknolabjournal.com/index.php/Jtl/article/view/447sars-cov-2; vaccination; igg covid-19. |
spellingShingle | Heri Setiyo Bekti I Gusti Agung Ayu Dharmawati Nur Habibah Fusvita Merdekawati Ganjar Noviar I Putu Suiraoka Luh Putu Rinawati Rike Syahniar M. Ibraar Ayatullah Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia Jurnal Teknologi Laboratorium sars-cov-2; vaccination; igg covid-19. |
title | Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia |
title_full | Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia |
title_fullStr | Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia |
title_full_unstemmed | Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia |
title_short | Post-vaccination SARS-COV-2 IgG Level: An evaluation study on 2 Area In Indonesia |
title_sort | post vaccination sars cov 2 igg level an evaluation study on 2 area in indonesia |
topic | sars-cov-2; vaccination; igg covid-19. |
url | https://teknolabjournal.com/index.php/Jtl/article/view/447 |
work_keys_str_mv | AT herisetiyobekti postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT igustiagungayudharmawati postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT nurhabibah postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT fusvitamerdekawati postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT ganjarnoviar postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT iputusuiraoka postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT luhputurinawati postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT rikesyahniar postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia AT mibraarayatullah postvaccinationsarscov2igglevelanevaluationstudyon2areainindonesia |